ARIWISE Tablet
Aripiprazole Tablets – PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
| Composition | Aripiprazole IP 5 mg / 10 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Alu-Alu |
| Available Strengths | ARIWISE-5, ARIWISE-10 |
| MRP | See strength-wise pricing below |
| Therapy | Psychiatry – Schizophrenia & bipolar disorder — Atypical antipsychotic (dopamine D2 partial agonist) |
| Storage | Store below 30 °C in a dry place, protected from light. Keep out of reach of children. |
📱 WhatsApp Enquiry📞 Call: +919041677932
For chemists, distributors and doctors: ARIWISE (aripiprazole 5 mg / 10 mg tablets) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
See the full neuro & psychiatry range – manufacturer, supplier and PCD franchise: antiepileptics, antidepressants, antipsychotics, pregabalin and gabapentin, dementia and vertigo medicines.
See the full gastro range – manufacturer, supplier and PCD franchise: pantoprazole, rabeprazole, esomeprazole, vonoprazan, domperidone, ondansetron, sucralfate, antacids, laxatives and liver medicines.
Available Strengths
ARIWISE is available in two strengths, both packed 10 x 10 tablets in Alu-Alu strips.
ARIWISE-5

| Concentration | Aripiprazole 5 mg |
|---|---|
| Delivers | Starting / lower dose |
| Pack | 10 x 10 Tablets |
| MRP | ₹ 990 |
ARIWISE-10

| Concentration | Aripiprazole 10 mg |
|---|---|
| Delivers | Usual starting dose in schizophrenia |
| Pack | 10 x 10 Tablets |
| MRP | ₹ 1380 |
About ARIWISE Tablet
ARIWISE is Trumac Healthcare’s aripiprazole tablet IP in two strengths – ARIWISE-5 (5 mg, MRP ₹990) and ARIWISE-10 (10 mg, MRP ₹1,380), each 10 x 10 tablets in Alu-Alu packs – made for Trumac at WHO-GMP certified partner units.
Aripiprazole is a widely prescribed atypical antipsychotic. Psychiatrists use it for schizophrenia and for manic episodes of bipolar I disorder, and it is valued because it causes less weight gain, prolactin rise and sedation than many older antipsychotics.
For PCD partners in the neuro-psychiatry segment, ARIWISE adds a high-repeat chronic-therapy product next to Trumac’s risperidone, escitalopram and other CNS brands.
Indications
- Schizophrenia in adults and adolescents, as prescribed by a psychiatrist
- Manic or mixed episodes of bipolar I disorder, and prevention of new manic episodes
- Add-on treatment in depression or other conditions only where the specialist advises
Mechanism of Action
Aripiprazole is a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at 5-HT2A receptors. It lowers dopamine activity where it is too high and raises it where it is too low, which controls psychotic and manic symptoms with a lower risk of movement side effects and prolactin rise.
Dosage & Administration
Once a day, with or without food, at about the same time. Schizophrenia: usually 10–15 mg a day (maximum 30 mg). Bipolar mania: usually 15 mg a day. The dose is adjusted by the psychiatrist and must be reduced when strong CYP2D6 or CYP3A4 inhibitors (e.g. fluoxetine, paroxetine, ketoconazole) are given. Do not stop suddenly without medical advice.
Side Effects
Restlessness or an inner urge to move (akathisia), insomnia, headache, nausea, dizziness, sleepiness and blurred vision. Compulsive behaviour – pathological gambling, binge eating, compulsive shopping or sexual urges – has been reported; patients and families should report it. Rarely tardive dyskinesia, neuroleptic malignant syndrome (fever, stiffness, confusion – stop and seek care at once), high blood sugar, seizures and low white-cell counts.
Contraindications & Precautions
Do not use in allergy to aripiprazole. Elderly patients with dementia-related psychosis treated with antipsychotics have a higher risk of death and stroke – aripiprazole is not approved for this use. Young people treated for depression should be watched for suicidal thoughts. Use with care in heart disease, low blood pressure, epilepsy, diabetes, history of compulsive behaviour, pregnancy and breastfeeding. Avoid alcohol.
Storage
Store below 30 °C in a dry place, protected from light. Keep out of reach of children.
ARIWISE Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the neuro-psychiatry products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare neuro PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.
Frequently Asked Questions
Who supplies aripiprazole tablets for PCD franchise?
ARIWISE is made for Trumac Healthcare at WHO-GMP certified partner units and offered on a PCD pharma franchise with monopoly rights for your district. No franchise fee; first order from ₹25,000.
Can distributors buy ARIWISE on wholesale?
Yes. Licensed distributors, wholesalers and chemists can buy it in bulk – message us on WhatsApp for net rates. Orders are usually dispatched within 48 hours of confirmation.
Is aripiprazole available for third party manufacturing?
Trumac has no plant of its own; its products are made at WHO-GMP certified partner units. For your own brand, share the quantity and label details and we will tell you what is possible.
What are the strengths, packs and MRPs of ARIWISE?
ARIWISE-5 (aripiprazole 5 mg) MRP ₹990 and ARIWISE-10 (aripiprazole 10 mg) MRP ₹1,380, each 10 x 10 tablets in Alu-Alu packs, as per the current product list.
Does aripiprazole cause weight gain?
Less than most other atypical antipsychotics, but weight, blood sugar and lipids should still be checked during long-term treatment.
